Despite recent progress, to our knowledge there has been no comprehensive and systematic examination of the association between polygenic liability to schizophrenia and substance use disorder, which has been carefully assessed for licit and illicit substances. For these analyses, we leverage studies systematically ascertained for substance use disorder to determine whether the schizophrenia polygenic risk scores are associated with these substance dependences.
